Fmoc-leu-bt
Modify Date: 2024-01-09 14:44:14
Fmoc-leu-bt structure
|
Common Name | Fmoc-leu-bt | ||
|---|---|---|---|---|
| CAS Number | 1072840-99-3 | Molecular Weight | 454.52000 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C27H26N4O3 | Melting Point | N/A | |
| MSDS | Chinese USA | Flash Point | N/A | |
Use of Fmoc-leu-btFmoc-leu-bt is a leucine derivative[1]. |
| Name | 9H-fluoren-9-ylmethyl N-[(2S)-1-(benzotriazol-1-yl)-4-methyl-1-oxopentan-2-yl]carbamate |
|---|---|
| Synonym | More Synonyms |
| Description | Fmoc-leu-bt is a leucine derivative[1]. |
|---|---|
| Related Catalog | |
| In Vitro | Amino acids and amino acid derivatives have been commercially used as ergogenic supplements. They influence the secretion of anabolic hormones, supply of fuel during exercise, mental performance during stress related tasks and prevent exercise induced muscle damage. They are recognized to be beneficial as ergogenic dietary substances[1]. |
| References |
| Molecular Formula | C27H26N4O3 |
|---|---|
| Molecular Weight | 454.52000 |
| Exact Mass | 454.20000 |
| PSA | 86.11000 |
| LogP | 5.41580 |
| RIDADR | NONH for all modes of transport |
|---|
| Precursor 2 | |
|---|---|
| DownStream 0 | |
|
Abdelmajeid, A.; et al.
Synthesis , 2995-3005, (2011)
|
|
|
Katritzky, A. R.; et al.
J. Org. Chem. 74th ed.,, 8690-8694, (2009)
|
|
|
Avan, I.; et al.
J. Org. Chem. 76th ed.,, 4884-4893, (2011)
|
| N-Fmoc-L-Leu-Bt |
| Fmoc-leu-bt |
| Fmoc-Leu-Bt |
| S-(9H-fluoren-9-yl)methyl 1-(1H-benzotriazol-1-yl)-4-methyl-1-oxopentan-2-ylcarbamate |
| 9H-fluoren-9-ylmethyl N-[(2S)-1-(1,2,3-benzotriazol-1-yl)-4-methyl-1-oxopentan-2-yl]carbamate |